IL-2/anti-IL-2抗体复合体增强了对治疗性癌症疫苗的免疫反应
Miguel C Sobral1,2, Laura Cabizzosu1,2, Shawn J Kang1,2
1John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.
概括
将半孔杆 (MPS) 疫苗与IL-2抗体复合体 (IL-2cx) 结合起来,通过扩大树突细胞 (cDC) 和促进T细胞和NK细胞反应,显著增强抗瘤免疫力,从而提高了癌症疫苗的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 治疗性癌症疫苗开发面临高失败率,通常与传统树突细胞 (cDC) 的不充分参与有关.
- cDCs是关键的抗原呈现细胞 (APCs),用于启动抗瘤T细胞反应,使它们成为优化疫苗的关键目标.
研究的目的:
- 为了研究与CD122偏差IL-2/anti-IL-2抗体复合物 (IL-2cx) 结合中性杆 (MPS) 疫苗的疗效.
- 确定这种组合疗法是否增强cDC激活和随后的抗瘤免疫反应,包括T细胞和NK细胞活性.
主要方法:
- 小鼠接种了单独的MPS疫苗 (Vax) 或与IL-2cx (Vax+IL-2cx) 结合的疫苗.
- 流细胞计用于量化cDC,CD8+T细胞和NK细胞在接种地点,淋巴结和脏的数量.
- 使用模型蛋白抗原和新抗原测量了抗原特异性T细胞反应.
- 在MC38结肠癌和B16F10黑色素瘤瘤模型中评估了治疗疗效.
主要成果:
- 与Vax + IL-2cx治疗相比,与Vax单独治疗相比,在多个免疫隔间中cDC扩大了约3倍.
- 组合疗法导致CD8+T细胞增加了约3倍,NK细胞在接种部位增加了约15倍.
- 瓦克斯+IL-2cx诱导了循环中的抗原特异性CD8+T细胞的数量显著增加 (约5至30倍).
- 在50%的患有MC38结肠癌的小鼠中观察到完整的瘤回归,这些小鼠接受Vax+IL-2cx治疗,以cDC依赖的方式.
- 在B16F10黑色素瘤模型中,Vax+IL-2cx增加了NK细胞,并在瘤微环境中激活了cDCs.
结论:
- 将MPS疫苗与IL-2cx结合起来有效地增强了cDC的激活和扩张,这对于启动强大的抗瘤免疫反应至关重要.
- 这种组合策略显著增强了CD8+T细胞和NK细胞介导的抗瘤免疫力.
- 通过Vax+IL-2cx激活cDC-CD8+ T细胞和cDC-NK细胞轴,是改善治疗性癌症疫苗功效的有希望的方法.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.7K
09:31Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
9.1K
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Vaccinations
44.1K
Overview
44.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
